Related Experiment Video
Updated: Jul 16, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Immune reconstitution in patients with HIV infection
Gregory D Sempowski1, Barton F Haynes
1Department of Medicine and the Center For AIDS Research and Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina 27710, USA. gsem@acpub.duke.edu
Abstract:
The peripheral T cell pool is damaged by HIV-1 infection and can be regenerated by production of new T lymphocytes either from the thymus or from proliferation of post-thymic T cells. A critical question for AIDS patients is whether treatment with antiretroviral drugs can restore the capability to produce new T lymphocytes. The development of a new assay of thymus function in adults (the measurement of T cell receptor excision circles, TRECs), and studies of thymus biopsies in untreated and treated HIV-1-infected patients, have suggested that in select patients the thymus can regenerate on antiretroviral therapy. New strategies to overcome the thymic atrophy of aging are needed to improve thymic function in the majority of AIDS patients.
Related Concept Videos
Retrovirus Life Cycles
Cell-mediated Immune Responses
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Myocarditis III: Medical Management
Inhibitors of Viral Protein Synthesis

